Correlation Between Quoin Pharmaceuticals and Scisparc

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Quoin Pharmaceuticals and Scisparc at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Quoin Pharmaceuticals and Scisparc into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Quoin Pharmaceuticals Ltd and Scisparc, you can compare the effects of market volatilities on Quoin Pharmaceuticals and Scisparc and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Quoin Pharmaceuticals with a short position of Scisparc. Check out your portfolio center. Please also check ongoing floating volatility patterns of Quoin Pharmaceuticals and Scisparc.

Diversification Opportunities for Quoin Pharmaceuticals and Scisparc

-0.12
  Correlation Coefficient

Good diversification

The 3 months correlation between Quoin and Scisparc is -0.12. Overlapping area represents the amount of risk that can be diversified away by holding Quoin Pharmaceuticals Ltd and Scisparc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Scisparc and Quoin Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Quoin Pharmaceuticals Ltd are associated (or correlated) with Scisparc. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Scisparc has no effect on the direction of Quoin Pharmaceuticals i.e., Quoin Pharmaceuticals and Scisparc go up and down completely randomly.

Pair Corralation between Quoin Pharmaceuticals and Scisparc

Given the investment horizon of 90 days Quoin Pharmaceuticals Ltd is expected to generate 0.88 times more return on investment than Scisparc. However, Quoin Pharmaceuticals Ltd is 1.14 times less risky than Scisparc. It trades about 0.03 of its potential returns per unit of risk. Scisparc is currently generating about -0.18 per unit of risk. If you would invest  30.00  in Quoin Pharmaceuticals Ltd on December 5, 2024 and sell it today you would earn a total of  0.00  from holding Quoin Pharmaceuticals Ltd or generate 0.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Quoin Pharmaceuticals Ltd  vs.  Scisparc

 Performance 
       Timeline  
Quoin Pharmaceuticals 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Quoin Pharmaceuticals Ltd has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of abnormal performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in April 2025. The current disturbance may also be a sign of long term up-swing for the company investors.
Scisparc 

Risk-Adjusted Performance

OK

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Scisparc are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of rather uncertain basic indicators, Scisparc exhibited solid returns over the last few months and may actually be approaching a breakup point.

Quoin Pharmaceuticals and Scisparc Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Quoin Pharmaceuticals and Scisparc

The main advantage of trading using opposite Quoin Pharmaceuticals and Scisparc positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Quoin Pharmaceuticals position performs unexpectedly, Scisparc can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Scisparc will offset losses from the drop in Scisparc's long position.
The idea behind Quoin Pharmaceuticals Ltd and Scisparc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.

Other Complementary Tools

ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Global Correlations
Find global opportunities by holding instruments from different markets
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital